TG THERAPEUTICS INC (TGTX)
US88322Q1085 - Common Stock
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93.
TG Therapeutics stock spikes after setback to Merck KgaA (NASDAQ:TGTX)
TG Therapeutics (TGTX) shares rise as a rival drug for multiple sclerosis from Merck KgaA (MKGAF) (MKKGY) fails in two Phase 3 trials. Read more here.
TGTX stock price Has the TG Therapeutics train left the station?
TG Therapeutics (NASDAQ: TGTX) stock price continued its recovery after the company published strong financial results. The shares jumped to the psychologically important level of $15, its highest point since April 23rd. They have soared by more than 130% from their lowest level in October. TG Therapeutics earnings The main reason why the TGTX stock […]
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Fireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET...
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
Fireside chat scheduled for Monday, November 6, 2023, at 3:10 PM ET...
Notable Wednesday Option Activity: PLTR, EAT, TGTX
Why TG Therapeutics Stock Is Crushing It Today
The biopharmaceutical company's Q3 update was music to investors' ears.
TG Therapeutics stock gains after Q3 beat (NASDAQ:TGTX)
TG Therapeutics (TGTX) reports strong Q3 2023 financials, driven by licensing revenue and sales from its multiple sclerosis therapy Briumvi. Read more here.
TG Therapeutics GAAP EPS of $0.73 beats by $0.56, revenue of $165.82M beats by $102.48M (NASDAQ:TGTX)
TG Therapeutics reports third quarter 2023 financial results, beating expectations with GAAP EPS of $0.73 and revenue of $165.82M.
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
Third quarter 2023 total net revenue of $165.8 million, including quarterly BRIUMVI® net sales of $25.1 million in the United States, and license revenue...
TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update
Conference call to be held Wednesday, November 1, 2023, at 8:30 AM ET...
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the presentation of data from the ULTIMATE I & II...
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the presentation of data from both the ULTIMATE I &...
TG Therapeutics (TGTX) stock price has plunged: buy the dip?
TG Therapeutics (NASDAQ: TGTX) stock price sell-off continued this week as concerns about the rising competition continued. The shares plunged to a low of $7.53 on Wednesday, much lower than the year-to-date high of $35.56. Roche competition worries TG Therapeutics started the year well after the company gained FDA-approved Briumvi, a drug that treats relapsing […]
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations, highlighting data...
Interesting TGTX Put And Call Options For November 10th
TG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
Fireside chat scheduled for Tuesday, September 26, 2023, at 12:25 PM ET...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such...
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Fireside chat scheduled for Monday, September 11, 2023, at 10:30 AM ET...
3 Very Oversold Biotech Stocks to Buy Right Now
These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong.
Top Buys by Directors: Weiss's $1M Bet on TGTX